Systemic Sclerosis and Pulmonary Disease

Area of Science:

• Immunology
• Rheumatology
• Pulmonology

Background:

• Systemic sclerosis is a complex, multisystem autoimmune disease characterized by progressive fibrosis.
• Lung disease is a common and serious complication, now the leading cause of mortality.
• Disease presentation varies, with limited cutaneous systemic sclerosis often associated with pulmonary hypertension and diffuse cutaneous systemic sclerosis with interstitial lung disease.

Purpose of the Study:

• To highlight the significance of lung complications in systemic sclerosis.
• To differentiate the lung manifestations based on systemic sclerosis subtypes.
• To emphasize the importance of early diagnosis for effective management.

Main Methods:

• Review of systemic sclerosis classification and common manifestations.
• Analysis of lung disease prevalence and mortality in systemic sclerosis.
• Correlation of cutaneous manifestations and autoantibodies with specific lung pathologies.

Main Results:

• Severe lung disease is the primary cause of mortality in systemic sclerosis.
• Limited cutaneous systemic sclerosis typically presents with pulmonary hypertension.
• Diffuse cutaneous systemic sclerosis commonly involves interstitial lung disease.
• Rare phenotypes may exhibit both pulmonary hypertension and interstitial lung disease.

Conclusions:

• Lung complications are critical in systemic sclerosis management.
• Identifying specific lung disease subtypes based on systemic sclerosis phenotype is crucial.
• Early diagnosis and targeted treatment are essential for improving outcomes in systemic sclerosis-associated lung disease.